SidaSubSaharaV1, PubMed, Corpus, bibRecord, 001894

Explaining adherence success in sub-Saharan Africa: an ethnographic study.

Identifieur interne : 001894 ( PubMed/Corpus ); précédent : 001893; suivant : 001895

Explaining adherence success in sub-Saharan Africa: an ethnographic study.

Auteurs : Norma C. Ware ; John Idoko ; Sylvia Kaaya ; Irene Andia Biraro ; Monique A. Wyatt ; Oche Agbaji ; Guerino Chalamilla ; David R. Bangsberg

Source :

PLoS medicine [ 1549-1676 ] ; 2009.

RBID : pubmed:19175285

English descriptors

KwdEn :
- Acquired Immunodeficiency Syndrome (drug therapy), Adult, Africa South of the Sahara, Anthropology, Cultural, Anti-Retroviral Agents (therapeutic use), Female, Health Care Costs, Humans, Interviews as Topic, Male, Patient Compliance (ethnology), Social Support, Socioeconomic Factors.
MESH :
- chemical , therapeutic use : Anti-Retroviral Agents.
- geographic : Africa South of the Sahara.
- drug therapy : Acquired Immunodeficiency Syndrome.
- ethnology : Patient Compliance.
- Adult, Anthropology, Cultural, Female, Health Care Costs, Humans, Interviews as Topic, Male, Social Support, Socioeconomic Factors.

Abstract

Individuals living with HIV/AIDS in sub-Saharan Africa generally take more than 90% of prescribed doses of antiretroviral therapy (ART). This number exceeds the levels of adherence observed in North America and dispels early scale-up concerns that adherence would be inadequate in settings of extreme poverty. This paper offers an explanation and theoretical model of ART adherence success based on the results of an ethnographic study in three sub-Saharan African countries.

DOI: 10.1371/journal.pmed.1000011
PubMed: 19175285

Links to Exploration step

pubmed:19175285

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Explaining adherence success in sub-Saharan Africa: an ethnographic study.</title>
<author><name sortKey="Ware, Norma C" sort="Ware, Norma C" uniqKey="Ware N" first="Norma C" last="Ware">Norma C. Ware</name>
<affiliation><nlm:affiliation>Harvard Medical School, Boston, Massachusetts, United States of America. norma_ware@hms.harvard.edu</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Idoko, John" sort="Idoko, John" uniqKey="Idoko J" first="John" last="Idoko">John Idoko</name>
</author>
<author><name sortKey="Kaaya, Sylvia" sort="Kaaya, Sylvia" uniqKey="Kaaya S" first="Sylvia" last="Kaaya">Sylvia Kaaya</name>
</author>
<author><name sortKey="Biraro, Irene Andia" sort="Biraro, Irene Andia" uniqKey="Biraro I" first="Irene Andia" last="Biraro">Irene Andia Biraro</name>
</author>
<author><name sortKey="Wyatt, Monique A" sort="Wyatt, Monique A" uniqKey="Wyatt M" first="Monique A" last="Wyatt">Monique A. Wyatt</name>
</author>
<author><name sortKey="Agbaji, Oche" sort="Agbaji, Oche" uniqKey="Agbaji O" first="Oche" last="Agbaji">Oche Agbaji</name>
</author>
<author><name sortKey="Chalamilla, Guerino" sort="Chalamilla, Guerino" uniqKey="Chalamilla G" first="Guerino" last="Chalamilla">Guerino Chalamilla</name>
</author>
<author><name sortKey="Bangsberg, David R" sort="Bangsberg, David R" uniqKey="Bangsberg D" first="David R" last="Bangsberg">David R. Bangsberg</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19175285</idno>
<idno type="pmid">19175285</idno>
<idno type="doi">10.1371/journal.pmed.1000011</idno>
<idno type="wicri:Area/PubMed/Corpus">001894</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001894</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Explaining adherence success in sub-Saharan Africa: an ethnographic study.</title>
<author><name sortKey="Ware, Norma C" sort="Ware, Norma C" uniqKey="Ware N" first="Norma C" last="Ware">Norma C. Ware</name>
<affiliation><nlm:affiliation>Harvard Medical School, Boston, Massachusetts, United States of America. norma_ware@hms.harvard.edu</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Idoko, John" sort="Idoko, John" uniqKey="Idoko J" first="John" last="Idoko">John Idoko</name>
</author>
<author><name sortKey="Kaaya, Sylvia" sort="Kaaya, Sylvia" uniqKey="Kaaya S" first="Sylvia" last="Kaaya">Sylvia Kaaya</name>
</author>
<author><name sortKey="Biraro, Irene Andia" sort="Biraro, Irene Andia" uniqKey="Biraro I" first="Irene Andia" last="Biraro">Irene Andia Biraro</name>
</author>
<author><name sortKey="Wyatt, Monique A" sort="Wyatt, Monique A" uniqKey="Wyatt M" first="Monique A" last="Wyatt">Monique A. Wyatt</name>
</author>
<author><name sortKey="Agbaji, Oche" sort="Agbaji, Oche" uniqKey="Agbaji O" first="Oche" last="Agbaji">Oche Agbaji</name>
</author>
<author><name sortKey="Chalamilla, Guerino" sort="Chalamilla, Guerino" uniqKey="Chalamilla G" first="Guerino" last="Chalamilla">Guerino Chalamilla</name>
</author>
<author><name sortKey="Bangsberg, David R" sort="Bangsberg, David R" uniqKey="Bangsberg D" first="David R" last="Bangsberg">David R. Bangsberg</name>
</author>
</analytic>
<series><title level="j">PLoS medicine</title>
<idno type="eISSN">1549-1676</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acquired Immunodeficiency Syndrome (drug therapy)</term>
<term>Adult</term>
<term>Africa South of the Sahara</term>
<term>Anthropology, Cultural</term>
<term>Anti-Retroviral Agents (therapeutic use)</term>
<term>Female</term>
<term>Health Care Costs</term>
<term>Humans</term>
<term>Interviews as Topic</term>
<term>Male</term>
<term>Patient Compliance (ethnology)</term>
<term>Social Support</term>
<term>Socioeconomic Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Retroviral Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Africa South of the Sahara</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="ethnology" xml:lang="en"><term>Patient Compliance</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Anthropology, Cultural</term>
<term>Female</term>
<term>Health Care Costs</term>
<term>Humans</term>
<term>Interviews as Topic</term>
<term>Male</term>
<term>Social Support</term>
<term>Socioeconomic Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Individuals living with HIV/AIDS in sub-Saharan Africa generally take more than 90% of prescribed doses of antiretroviral therapy (ART). This number exceeds the levels of adherence observed in North America and dispels early scale-up concerns that adherence would be inadequate in settings of extreme poverty. This paper offers an explanation and theoretical model of ART adherence success based on the results of an ethnographic study in three sub-Saharan African countries.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19175285</PMID>
<DateCreated><Year>2009</Year>
<Month>01</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted><Year>2009</Year>
<Month>03</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>10</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1549-1676</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>6</Volume>
<Issue>1</Issue>
<PubDate><Year>2009</Year>
<Month>Jan</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>PLoS medicine</Title>
<ISOAbbreviation>PLoS Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Explaining adherence success in sub-Saharan Africa: an ethnographic study.</ArticleTitle>
<Pagination><MedlinePgn>e11</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pmed.1000011</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Individuals living with HIV/AIDS in sub-Saharan Africa generally take more than 90% of prescribed doses of antiretroviral therapy (ART). This number exceeds the levels of adherence observed in North America and dispels early scale-up concerns that adherence would be inadequate in settings of extreme poverty. This paper offers an explanation and theoretical model of ART adherence success based on the results of an ethnographic study in three sub-Saharan African countries.</AbstractText>
<AbstractText Label="METHODS AND FINDINGS" NlmCategory="RESULTS">Determinants of ART adherence for HIV-infected persons in sub-Saharan Africa were examined with ethnographic research methods. 414 in-person interviews were carried out with 252 persons taking ART, their treatment partners, and health care professionals at HIV treatment sites in Jos, Nigeria; Dar es Salaam, Tanzania; and Mbarara, Uganda. 136 field observations of clinic activities were also conducted. Data were examined using category construction and interpretive approaches to analysis. Findings indicate that individuals taking ART routinely overcome economic obstacles to ART adherence through a number of deliberate strategies aimed at prioritizing adherence: borrowing and "begging" transport funds, making "impossible choices" to allocate resources in favor of treatment, and "doing without." Prioritization of adherence is accomplished through resources and help made available by treatment partners, other family members and friends, and health care providers. Helpers expect adherence and make their expectations known, creating a responsibility on the part of patients to adhere. Patients adhere to promote good will on the part of helpers, thereby ensuring help will be available when future needs arise.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Adherence success in sub-Saharan Africa can be explained as a means of fulfilling social responsibilities and thus preserving social capital in essential relationships.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ware</LastName>
<ForeName>Norma C</ForeName>
<Initials>NC</Initials>
<AffiliationInfo><Affiliation>Harvard Medical School, Boston, Massachusetts, United States of America. norma_ware@hms.harvard.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Idoko</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kaaya</LastName>
<ForeName>Sylvia</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Biraro</LastName>
<ForeName>Irene Andia</ForeName>
<Initials>IA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wyatt</LastName>
<ForeName>Monique A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Agbaji</LastName>
<ForeName>Oche</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y"><LastName>Chalamilla</LastName>
<ForeName>Guerino</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bangsberg</LastName>
<ForeName>David R</ForeName>
<Initials>DR</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>K24 AA015287</GrantID>
<Acronym>AA</Acronym>
<Agency>NIAAA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 MH054907</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R21 MH077539</GrantID>
<Acronym>MH</Acronym>
<Agency>NIMH NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS Med</MedlineTA>
<NlmUniqueID>101231360</NlmUniqueID>
<ISSNLinking>1549-1277</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D044966">Anti-Retroviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Niger J Med. 2005 Jul-Sep;14(3):290-4</RefSource>
<PMID Version="1">16350700</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2005 May;10(5):464-70</RefSource>
<PMID Version="1">15860093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2006 Jun 1;42(11):1619-27</RefSource>
<PMID Version="1">16652320</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2005 Dec;2(12):e338</RefSource>
<PMID Version="1">16187735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Health Psychol. 2006 Jul;25(4):462-73</RefSource>
<PMID Version="1">16846321</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Behav. 2006 Jul;10(4):437-42</RefSource>
<PMID Version="1">16636892</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>JAMA. 2006 Aug 9;296(6):679-90</RefSource>
<PMID Version="1">16896111</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2006 Nov 4;368(9547):1587-94</RefSource>
<PMID Version="1">17084759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S123-6</RefSource>
<PMID Version="1">17133195</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S127-33</RefSource>
<PMID Version="1">17133196</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):71-6</RefSource>
<PMID Version="1">17031319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2007;19 Suppl 1:S54-63</RefSource>
<PMID Version="1">17364388</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2007;19 Suppl 1:S73-82</RefSource>
<PMID Version="1">17364390</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2007 May 11;21(8):965-71</RefSource>
<PMID Version="1">17457090</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2007 May;19(5):658-65</RefSource>
<PMID Version="1">17505927</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2007 Jul 11;21(11):1486-7</RefSource>
<PMID Version="1">17589198</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):355-8</RefSource>
<PMID Version="1">17438479</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2007 Sep 15;45(6):770-8</RefSource>
<PMID Version="1">17712763</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>S Afr Med J. 2007 Jul;97(7):524-9</RefSource>
<PMID Version="1">17805455</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2007 Oct;21 Suppl 5:S31-5</RefSource>
<PMID Version="1">18090265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Patient Care STDS. 2008 Mar;22(3):173-4</RefSource>
<PMID Version="1">18290750</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):611-9</RefSource>
<PMID Version="1">18645509</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2006 Jan 15;42(2):252-9</RefSource>
<PMID Version="1">16355337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2000 Jun;12(3):255-66</RefSource>
<PMID Version="1">10928201</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2001 Aug 4;358(9279):410-4</RefSource>
<PMID Version="1">11502341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2001;79(12):1145-51</RefSource>
<PMID Version="1">11799447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2002 Mar 8;16(4):676-8</RefSource>
<PMID Version="1">11873017</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS. 2003 Jun 13;17(9):1369-75</RefSource>
<PMID Version="1">12799558</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):281-8</RefSource>
<PMID Version="1">14600572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMJ. 2004 Jan 31;328(7434):280-2</RefSource>
<PMID Version="1">14751902</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S429-36</RefSource>
<PMID Version="1">15156434</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2004 Jul 3-9;364(9428):29-34</RefSource>
<PMID Version="1">15234853</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1100-2</RefSource>
<PMID Version="1">15247564</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1979 Feb;109(2):186-204</RefSource>
<PMID Version="1">425958</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Science. 1988 Jul 29;241(4865):540-5</RefSource>
<PMID Version="1">3399889</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Soc Sci Med. 1991;33(2):177-83</RefSource>
<PMID Version="1">1887281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychol Bull. 1996 May;119(3):488-531</RefSource>
<PMID Version="1">8668748</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2004 Oct;20(10):1053-6</RefSource>
<PMID Version="1">15585095</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):14-7</RefSource>
<PMID Version="1">15608518</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J STD AIDS. 2005 Jan;16(1):38-41</RefSource>
<PMID Version="1">15705271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>PLoS Med. 2009 Jan 27;6(1):e18</RefSource>
<PMID Version="1">19175286</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017954" MajorTopicYN="N" Type="Geographic">Africa South of the Sahara</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000884" MajorTopicYN="N">Anthropology, Cultural</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D044966" MajorTopicYN="N">Anti-Retroviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017048" MajorTopicYN="N">Health Care Costs</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010349" MajorTopicYN="N">Patient Compliance</DescriptorName>
<QualifierName UI="Q000208" MajorTopicYN="Y">ethnology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012944" MajorTopicYN="Y">Social Support</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC2631046</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year>
<Month>06</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2008</Year>
<Month>11</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>1</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>1</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>3</Month>
<Day>5</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19175285</ArticleId>
<ArticleId IdType="pii">08-PLME-RA-1572</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pmed.1000011</ArticleId>
<ArticleId IdType="pmc">PMC2631046</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001894 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001894 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:19175285
   |texte=   Explaining adherence success in sub-Saharan Africa: an ethnographic study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:19175285" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaSubSaharaV1

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024

	Le SIDA en Afrique subsaharienne (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA en Afrique subsaharienne (serveur d'exploration)

Explaining adherence success in sub-Saharan Africa: an ethnographic study.

Explaining adherence success in sub-Saharan Africa: an ethnographic study.

Source :

English descriptors

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki